NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Australia says Italy's block on AstraZeneca vaccine frustrating but not crucial

Published 05/03/2021, 12:20 pm
Updated 05/03/2021, 12:24 pm
© Reuters.
CSL
-
AZN
-
PFE
-
AZN
-

By Colin Packham

CANBERRA, March 5 (Reuters) - The Australian government on Friday expressed frustration at Italy's decision to block a shipment of AstraZeneca (NASDAQ:AZN)'s AZN.L COVID-19 vaccine, but stressed it would not affect the rollout of Australia's inoculation program.

Italy, supported by the European Commission, blocked the planned export of around 250,000 doses of AstraZeneca's vaccine after the drug manufacturer failed to meet its European Union contract commitments. world is in unchartered territory at present, it's unsurprising that some countries would tear up the rule book," Australian Finance Minister Simon Birmingham told Sky News.

"This is a demonstration of really how well Australia continues to do compared to the desperation of other countries."

Health Minister Greg Hunt said Australia had already received 300,000 doses of AstraZeneca's COVID-19 vaccine, which would last until local production of the vaccine ramps up.

"This is one shipment from one country," Hunt said in an emailed statement. "This shipment was not factored into our distribution plan for coming weeks."

AstraZeneca did not immediately reply to a request for comment.

Australia began its inoculation programme two weeks ago, vaccinating frontline health staff and senior citizens with Pfizer (NYSE:PFE)'s PFE.N COVID-19 vaccine though doses of that vaccine are limited amid tight global supplies.

Officials on Friday administered the first AstraZeneca vaccine to a doctor in South Australia state.

Australia has ordered 53.8 million doses of the AstraZeneca vaccine, which was developed in conjunction with the University of Oxford. Local pharmaceutical company CSL Ltd CSL.AX has secured the rights to manufacture 50 million of those doses in Australia.

Those doses will provide the backbone of Australia's inoculation programme, which it hopes to complete by October.

Australia is under less pressure than many other countries, having recorded just under 29,000 COVID-19 cases and 909 deaths. The lower infection and death tallies have been helped by strict lockdowns, speedy tracking systems and border closures.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.